// COMPANY
BioReference Health
SECTOR HEALTHTECHMENTIONS 1LAST SEEN OCTOBER 16, 2026
// RECENT MENTIONS
// SIGNALS
1 SIGNAL
01
m_and_a·Axios Pro Rata·OCTOBER 16, 2026
“agreed to buy the lab testing business of BioReference Health from OPKO Health for $722m in cash upfront and $150m of potential earnouts.”
AI-extracted from podcast / newsletter / paper summaries. May contain errors.